CAVA Crushes Q2 Estimates and Stock Surges 13%, but Can a Mediterranean Chain Keep Outrunning a Cyclospora Cloud and a Premium Price Tag?

Shares of CAVA Group rocketed 13.4% to $69.01 on August 12 after the fast-casual Mediterranean chain reported second-quarter results that blew past Wall Street forecasts on nearly every line. Revenue hit $365.4 million, a 31.3% year-over-year jump that cleared the consensus mark of $353.3 million . Same-restaurant sales — a measure of how much existing locations grow — rose 9.0%, while adjusted EBITDA (a proxy for operating cash profit) reached $54.7 million, topping the roughly $50 million analysts had modeled . The company reiterated its full-year guidance rather than raising it, leaving investors to parse whether that reflects caution or confidence.

- The Beat Extends a Streak That's Hard to Ignore. CAVA has beaten the Zacks Consensus Estimate in three of the trailing four quarters, with an average surprise of 16.6% . Q2's 9.0% same-restaurant sales growth dwarfs Chipotle's 2.2% comp increase in the same period , confirming CAVA as the standout performer in fast-casual dining. That consistency is what keeps the growth premium alive.

- A Nationwide Food-Safety Scare Looms Over Q3. CAVA recently reported a 4.2% decline in customer visits following a cyclospora outbreak traced to Mexico-sourced iceberg lettuce . Illnesses linked to the outbreak began June 22 and have led to at least 98 hospitalizations . The Q2 numbers predate the worst of the scare, which means management's decision to reiterate rather than raise guidance may be a tacit nod that July and August traffic took a hit.

- The Stock Was Deeply Discounted — and Analysts Still See Upside. Before this beat, shares had shed 29% year-over-year and were testing support at the $60 level . Even after today's jump, the stock sits well below the Street's mean price target of $91 , backed by 14 buys, 4 outperforms, 8 holds, and 1 sell . That gap suggests most analysts view the selloff as overdone — if the food-safety overhang fades.

- Guidance Tells the Real Story. Management had raised its full-year 2026 guidance after Q1 to 75–77 net new restaurants, same-restaurant sales growth of 4.5%–6.5%, and adjusted EBITDA of $181 million to $191 million . With two quarters already running near 9%+ comps, holding the top of that range at 6.5% implies management is bracing for a meaningful deceleration in the back half — likely cyclospora-related. Investors who see that conservatism as sandbagging will buy; those who take it at face value will wait.